About Immune Biosolutions

They are founded in 2012 by three entrepreneurial scientists, hoping to devise a full-proof platform for the discovery of clinically-relevant antibodies. Over the years, they have been supported by many prestigious entrepreneurship and scientific awards to create our Nebula Antibody platform and have substantiated this platform through several collaborations with various North American and European pharmaceutical partners. We have also produced over 350 commercial antibodies and submitted severa

Company Highlights
Year Founded

2012

icon-altEmployees

26

Location (HQ)

CAN

Since Last Funding

3 years 5 months

Monthly Website Visitors

2.6K

icon-altTotal Investment Amt

$11M

Last Funding Round

Grant

icon-altMoM Headcount Growth

-3.69%

icon-altYoY Headcount Growth

-10.31%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Biotechnology Research

Pharmaceutical